Stem Point Capital LP Applied Therapeutics Inc. Transaction History
Stem Point Capital LP
- $334 Billion
- Q3 2024
A detailed history of Stem Point Capital LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 1,554,586 shares of APLT stock, worth $14.3 Million. This represents 3.96% of its overall portfolio holdings.
Number of Shares
1,554,586
Previous 2,211,320
29.7%
Holding current value
$14.3 Million
Previous $10.3 Billion
27.96%
% of portfolio
3.96%
Previous 3.03%
Shares
4 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$97.1 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$91.2 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$90.5 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$73.7 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$62.6 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $442M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...